Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada

Bobby Shayegan, Christopher J.D. Wallis, Shawn Malone, Ilias Cagiannos, Robert J. Hamilton, Cristano Ferrario, Geoffrey T. Gotto, Naveen S. Basappa, Scott C. Morgan, Ricardo Fernandes, Christopher Morash, Tamim Niazi, Krista L. Noonan, Ricardo Rendon, Brendan Osborne, Laura Park-Wyllie, Katherine F.Y. Chan, Sebastien J. Hotte, Fred Saad

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)192.e1-192.e9
JournalUrologic Oncology: Seminars and Original Investigations
Volume40
Issue number5
DOIs
Publication statusPublished - May 2022

ASJC Scopus Subject Areas

  • Urology
  • Oncology

Keywords

  • Metastatic prostate cancer
  • Population-based
  • Real-world outcome
  • Systemic therapies

Fingerprint

Dive into the research topics of 'Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada'. Together they form a unique fingerprint.

Cite this